Item 9 Labs Corp
OTC:INLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Item 9 Labs Corp
OTC:INLB
|
701.8 USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Item 9 Labs Corp
Glance View
Item 9 Labs Corp. is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The company is headquartered in Phoenix, Arizona and currently employs 103 full-time employees. The company went IPO on 2011-11-03. The firm produces cannabis and cannabis-related products and offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vape products as well as premium concentrates and Orion vape technologies. The firm's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The firm also offers a dispensary franchise model through the national Unity Rd. retail brand. Item 9 Labs cultivates elevated mainstream cannabis flower, vape cartridges, concentrates and Apollo & Orion vape technologies. The Company’s products are available to consumers through licensed dispensaries in Arizona. Its products are carried in more than 70 dispensaries throughout the state of Arizona.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Item 9 Labs Corp is 49.8%, which is above its 3-year median of 46.8%.
Over the last 3 years, Item 9 Labs Corp’s Gross Margin has increased from 36.9% to 49.8%. During this period, it reached a low of 33.4% on Jun 30, 2022 and a high of 49.8% on Jun 30, 2023.
